Hepatitis B virus (HBV) mutations associated with lamivudine resistance in human immunodeficiency virus (HIV)-infected patients.

被引：0
|
作者：
Thibault, V
Benhamou, Y
Seguret, C
Bocher, M
Katlama, C
Bricaire, F
Opolon, P
Poynard, T
Huraux, JM
机构：
[1] Grp Hosp Pitie Salpetriere, Serv Malad Infect, F-75634 Paris, France
[2] Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, F-75634 Paris, France
[3] Grp Hosp Pitie Salpetriere, Virol Lab, F-75634 Paris, France
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1291
引用
收藏
页码：485A / 485A
页数：1
相关论文
共 50 条
  • [1] Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus
    Thibault, V
    Benhamou, Y
    Seguret, C
    Bochet, M
    Katlama, C
    Bricaire, F
    Opolon, P
    Poynard, T
    Agut, H
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (09) : 3013 - 3016
  • [2] Characterisation and clinical significance of lamivudine resistant hepatitis B virus (HBV) mutations in human immunodeficiency virus (HIV) and HBV co-infected individuals
    Bartholomeusz, A
    Locarnini, S
    Ayres, A
    Cooley, L
    Lewin, S
    Crowe, S
    Mijch, A
    Roberts, S
    Sasadeusz, J
    ANTIVIRAL RESEARCH, 2003, 57 (03) : A43 - A43
  • [3] Efficacy of tenofovir disoproxil fumarate (TDF) for hepatitis B virus (HBV) in human immunodeficiency virus (HIV) infected patients.
    Benhamou, Y
    Piketty, C
    Katlama, C
    Rozembaum, W
    Neau, D
    Lafeuillade, A
    Rey, D
    Yazdanpanah, Y
    Trimoulet, P
    Fleury, H
    HEPATOLOGY, 2003, 38 (04) : 712A - 713A
  • [4] Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients
    Ramos, Belen
    Nunez, Marina
    Martin-Carbonero, Luz
    Sheldon, Julie
    Rios, Pilar
    Labarga, Pablo
    Romero, Miriam
    Barreiro, Pablo
    Garcia-Samaniego, Javier
    Soriano, Vincent
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 44 (05) : 557 - 561
  • [5] Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D
    Orhan Yιldιz
    Bilgehan Aygen
    Nese Demirtürk
    Tuna Demirdal
    Dilara Inan
    Taner Yιldιrmak
    Arzu Kantürk
    Ediz Tütüncü
    Hepatitis B Study Group
    World Journal of Gastroenterology, 2011, 17 (45) : 4987 - 4992
  • [6] Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D
    Yildiz, Orhan
    Aygen, Bilgehan
    Demirturk, Nese
    Demirdal, Tuna
    Inan, Dilara
    Yildirmak, Taner
    Kanturk, Arzu
    Tutuncu, Ediz
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (45) : 4987 - 4992
  • [7] Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients
    Benhamou, Y
    Bochet, M
    Thibault, V
    Di Martino, V
    Caumes, E
    Bricaire, F
    Opolon, P
    Katlama, C
    Poynard, T
    HEPATOLOGY, 1999, 30 (05) : 1302 - 1306
  • [8] Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil
    da Silva, Claudinei Mesquita
    de Peder, Leyde Daiane
    Guelere, Alessandra Michele
    Horvath, Josana Dranka
    Silva, Eraldo Schunk
    Vieira Teixeira, Jorge Juarez
    Bertolini, Dennis Armando
    PLOS ONE, 2018, 13 (09):
  • [9] Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort
    Wolters, LMM
    Niesters, HGM
    Hansen, BE
    van der Ende, ME
    Kroon, FP
    Richter, C
    Brinkman, K
    Meenhorst, PL
    de Man, RA
    JOURNAL OF CLINICAL VIROLOGY, 2002, 24 (03) : 173 - 181
  • [10] The risk of adefovir monotherapy in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infected patients
    Gelinck, LBS
    Claas, ECJ
    Kroon, FP
    JOURNAL OF HEPATOLOGY, 2005, 43 (02) : 360 - 361
12345